欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/0756/001
药品名称Oxaliplatin 5mg/ml Concentrate for Solution for Infusion
活性成分
    • oxaliplatin 5.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Accord Healthcare Ireland Ltd., Euro House, Euro Business Park, Little Island, Cork T45 K857, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 20075/0112 - 0029
    • Germany (DE)
      Oxaliplatin Acord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Austria (AT)
      Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Oxaliplatin Accord 5 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      OXALIPLATIN ACCORD 5 MG/ML
    • Hungary (HU)
      OXALIPLATIN ACCORD 5 mg/ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Oxaliplatin Accord
    • Czechia (CZ)
      Oxaliplatin Accord 5 mg/ml koncentrát pro přípravu infuzního roztoku
    • Romania (RO)
      Oxaliplatin Accord 5 mg/ml concentrat pentru solutie perfuzabila
    • Finland (FI)
许可日期2009/12/14
最近更新日期2024/04/09
药物ATC编码
    • L01XA03 oxaliplatin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase